Status:
COMPLETED
Intravenous Versus Intraperitoneal Instillation of Ondansetron for Decreasing Incidence of Nausea and Vomiting After Laparoscopic Gynecological Surgeries.
Lead Sponsor:
Zagazig University
Conditions:
Prevention
Eligibility:
FEMALE
21-60 years
Phase:
NA
Brief Summary
Study the effect of intraperitoneal instillation vs intravenous ondansetron on PONV added to intraperitoneal bupivacaine for enhanced recovery and to decrease incidence of PONV after laparoscopic surg...
Detailed Description
Laparoscopic surgeries have many advantages e.g., decreasing postoperative pain, better cosmetic, rapid recovery, and better recovery but also, it has side effects e.g., pain, postoperative nausea and...
Eligibility Criteria
Inclusion
- Written informed consent from the patient.
- Age: 21-60 years old.
- female patients
- Physical status: ASA 1\& II.
- BMI = ≤ 35 kg/m2).
- Type of operation: elective laparoscopic gynecological surgeries.
Exclusion
- Altered mental state.
- Patients with known history of allergy to the study drugs.
- hepatic, renal impairment or disease , cardiovascular, and respiratory diseases.
- Patients with chronic pain received NSAID or opioid during previous two weeks.
- Patients with history of PONV or motion sickness and patients received antiemetic therapy 24 h before the surgery.
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 26 2025
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT05317611
Start Date
July 1 2022
End Date
January 26 2025
Last Update
February 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
faculty of human medicine, Zagazig university hospitals
El Sharkia, Egypt